1 |
Ashktorab H, Nguza B, Fatemi M, et al (2011). Case-control study of vitamin D, dickkopfhomolog 1 (DKK1) gene methylation, VDR gene polymorphism and the risk of colon adenoma in african americans. PLoS One, 6, 25314.
DOI
|
2 |
Bai YH, Lu H, Hong D, et al (2012). Vitamin D receptor gene polymorphisms and colorectal cancer risk:a systematic metaanalysis. World J Gastroenterol, 18, 1672-9.
DOI
ScienceOn
|
3 |
Biancuzzo RM, Clarke N, Reitz RE, Travison TG, Holick M.F (2013). Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation. J Clin Endocrinol Metab, 98, 973-9.
DOI
|
4 |
Bid HK, Mishra DK, Mittal RD (2005). Vitamin-D receptor (VDR) gene (Fok1, Taq1 and Apa1) polymorphisms in healthy individuals from north Indian population. Asian Pac J Cancer Prev, 6, 147-52.
|
5 |
Bhanushali AA, Lajpal N, Kulkarni SS, et al (2009). Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25-hydroxyvitamin D levels. Indian J Hum Genet, 15, 108-13.
DOI
|
6 |
Bouillon R, Carmeliet G, Verlinden L, et al (2008).Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrine reviews, 29, 726-76.
DOI
ScienceOn
|
7 |
Byers SW, Rowlands T, Beildeck M, Bong YS (2012). Mechanism of action of vitamin D and the vitamin D receptor in colorectal cancer prevention and treatment. Rev Endocr Metab Disord, 13, 31-8.
DOI
|
8 |
Carlberg C (2003). Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res, 164, 29-42.
DOI
|
9 |
Carlberg C, Seuter S (2009). A genomic perspective on vitamin D signaling. Anticancer Res, 29, 3485-93.
|
10 |
Cunningham D, Atkin W, Lenz HJ, et al (2010). Colorectal cancer. The Lancet, 375, 1030-47.
DOI
ScienceOn
|
11 |
Dilmec F, Ozgonul A, Akkafa F, (2009). Determination of ApaI and TaqI polymorphisms of VDR gene in a group of Turkish patients with colorectal cancer. Internat J Hematol Oncol, 19, 18-22.
|
12 |
Freedman DM, Looker AC, Chang SC, Graubard BI. (2007). Prospective study of serum vitamin D and cancer mortality in the United States. J Nat Cancer Inst, 99, 1594-602.
DOI
|
13 |
Gunduz M, Cacyna C, Toptas B, et al (2012). Association of vitamin D receptor gene polymorphisms with colon cancer. Genet Test Mol Biomarkers, 16,1058-61.
DOI
ScienceOn
|
14 |
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al (2011). Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 96, 1911-30.
DOI
ScienceOn
|
15 |
Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR (2006). Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol, 57, 234-40.
DOI
ScienceOn
|
16 |
Haussler MR, Jurutka PW, Mizwicki M, Norman AW (2011).Vitamin D receptor (VDR)-mediated actions of ,25(OH)2vitamin D3: Genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab, 25, 543-59.
DOI
ScienceOn
|
17 |
Flugge J, Krusekopf S, Goldammer M, et al (2007). Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur J Clin Pharmacol, 63, 997-1005.
DOI
ScienceOn
|
18 |
Ingles SA, Ross RK, Yu MC, et al (1997). Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Nat Cancer Inst, 89,166-70
DOI
ScienceOn
|
19 |
Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al (2010). Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ, 340, 5500.
DOI
|
20 |
Jehan F, d'Alesio A, Garabedian M (2007). Exons and functional regions of the human vitamin D receptor gene around and within the main 1a promoter are well conserved among mammals. J Steroid Biochem Mol Boil, 103, 361-7.
DOI
|
21 |
Jones G (2008). Pharmacokinetics of vitamin D toxicity. American J Clin Nutr, 88, 582-6.
|
22 |
Jordan Cancer Registry, Cancer Incidence In Jordan 2010.
|
23 |
Larriba MJ, Munoz A (2005). SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications. Br J Cancer, 92, 985-9.
DOI
|
24 |
Kang K, Lee S, Jeon E, et al (2011). Emerging role of vitamin D in colorectal cancer. World J Gastrointest Oncol, 3, 123-7.
|
25 |
Kostner K, Denzer N, Muller CS, et al (2009). The Relevance of vitamin D receptor gene polymorphisms for cancer: a review of literature. Anticancer Research, 29, 3511-36.
|
26 |
Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A (2010). Guidelines working group "Primary colon cancer: ESMO clinical practice guidelines for diagnosis, adjuvant treatment and follow-up". Ann Oncol, 21, 70-7.
DOI
ScienceOn
|
27 |
Lips P (2007).Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol, 103, 620-5.
DOI
|
28 |
Mallah EM, Arafat TA, Hamad MF, et al (2011). Plasma concentrations of 25-hydroxyvitamin D among Jordanians: Effect of biological and habitual factors on vitamin D status. BMC Clin Pathol, 4, 11.
|
29 |
Marcinkowska E (2001). A run for a membrane vitamin D receptor. Biol Signals Recept, 10, 341-9.
DOI
|
30 |
Matusiak D, Murillo G, Carroll RE, Mehta RG, a Benya RV (2005). Expression of vitamin D receptor and 25-hydroxyvitaminD3-1a-hydroxylase in normal and malignant human colon. Cancer Epidemiol Biomarkers Prev, 14, 2370-6.
DOI
|
31 |
Minamitani K, Takahashi Y, Mingawa M, Yasuda T, Niimi H (1998). Difference in height associated with a translation start site polymorphism in the vitamin D receptor gene. Pediatr Res, 44, 628-32.
DOI
ScienceOn
|
32 |
Raimondi S, Johansson H, Maisonneuve P, Gandini S (2009). Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis, 30, 1170-80
DOI
ScienceOn
|
33 |
Natrah MS, Ezat S, Syed MA, Rizal AM, Saperi S (2014). Quality of life in Malaysian colorectal cancer patients: a preliminary result. Asian Pac J Cancer Prev, 13, 957-62.
과학기술학회마을
DOI
ScienceOn
|
34 |
Onen IH, Ekmekci A, Eroglu M, et al (2008). Association of genetic polymorphism in vitamin D receptor gene and susceptibility to sporadic prostate cancer. Exp Biol Med (Maywood), 233, 1608-14.
DOI
|
35 |
Pereira F, Larriba MJ, Munoz A (2012). Vitamin D and colon cancer. Endocr relat cancer, 19, 51-71
DOI
|
36 |
Richetta AG, Silvestri V, Giancristoforo S, et al (2014). A-1012G promoter polymorphism of vitamin D receptor gene is associated with psoriasis risk and lower allele-specific expression. DNA Cell Biol, 33, 102-9.
DOI
|
37 |
Ross AC, Taylor CL, Yaktine AL, Del valle HB (2011). Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press.
|
38 |
Slattery ML (2007).Vitamin D receptor gene (VDR) associations with cancer. Nutr Rev, 65, 102-4.
DOI
|
39 |
Slattery ML, Yakumo K, Hoffman M, Neuhausen S (2001). Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control, 12, 359-64.
DOI
ScienceOn
|
40 |
Seifert M, Tilgen W, Reichrath J (2009). Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro. Anticancer Res, 29, 3659-67.
|
41 |
Vuolo L, Di Somma C, Faggiano A, Colao A (2012). Vitamin D and cancer. Front Endocrinol, 3, 58.
|
42 |
Thacher TD, Clarke BL (2010).Vitamin D insufficiency. Mayo Clin Proc, 86, 50-60.
|
43 |
Tsiaras WG, Weinstock MA (2011). Factors influencing vitamin D status. Acta Derm Venereol, 91, 115-24.
|
44 |
Verstuyf A, Carmeliet G, Bouillon R, Mathieu C (2010).Vitamin D: a pleiotropic hormone. Kidney Int, 78, 140-5.
DOI
ScienceOn
|
45 |
Welsh J (2012). Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys, 523, 107-14.
DOI
ScienceOn
|
46 |
Woolcott CG, Wilkens LR, Nomura AM, et al (2010). Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 19, 130-4.
DOI
|
47 |
Yaylim-Eraltan I, Arzu Ergen H, Arikan S, et al (2007). Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer. Cell Biochem Funct, 25,731-7.
DOI
|
48 |
Yu K, Yang J, Jiang Y, Song R, Lu Q. (2014). Vitamin D receptor BsmI polymorphism and colorectal cancer risk: an updated analysis. Asian Pac J Cancer Prev, 15, 4801-7.
과학기술학회마을
DOI
|
49 |
Zheng W, Wong KE, Zhang Z, et al (2012). Inactivation of the vitamin D receptor in APCmin/1 mice reveals a critical role for the vitamin D receptor in intestinal tumor growth. Int J Cancer, 130, 10-9.
DOI
|
50 |
Zinser GM, Mceleney K, Welsh J (2003). Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice. Mol Cell Endocrinol, 200, 1-2.
DOI
|
51 |
Rasool S, Kadla SA, Khan T, et al (2013). Association of a VDR gene polymorphism with risk of colorectal cancer in Kashmir. Asian Pac J Cancer Prev, 14, 5833-7
과학기술학회마을
DOI
ScienceOn
|
52 |
Deeb KK, Trump DL, Johnson CS (2007). Vitamin D signaling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer, 7, 684-700.
DOI
ScienceOn
|
53 |
Arai H, Miyamoto KI, Yoshida M, et al (2001). The polymorphism in the caudal-related hemodomain protein Cdx-2 binding elements in the human vitamin D receptor gene. J Bone Miner Res, 16, 1256-64.
DOI
ScienceOn
|
54 |
Lee JE, Li H, Chan AT, et al (2011). Circulatory levels of vitamin D and colon and rectal cancer: Physicians health study and a meta-analysis of prospective studies. Cancer Prev Res, 4, 735-43.
DOI
ScienceOn
|